rs1802286

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001211.6(BUB1B):​c.2856C>T​(p.Asp952Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0253 in 1,610,922 control chromosomes in the GnomAD database, including 653 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.022 ( 57 hom., cov: 32)
Exomes 𝑓: 0.026 ( 596 hom. )

Consequence

BUB1B
NM_001211.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.77

Publications

9 publications found
Variant links:
Genes affected
BUB1B (HGNC:1149): (BUB1 mitotic checkpoint serine/threonine kinase B) This gene encodes a kinase involved in spindle checkpoint function. The protein has been localized to the kinetochore and plays a role in the inhibition of the anaphase-promoting complex/cyclosome (APC/C), delaying the onset of anaphase and ensuring proper chromosome segregation. Impaired spindle checkpoint function has been found in many forms of cancer. [provided by RefSeq, Jul 2008]
BUB1B-PAK6 (HGNC:52276): (BUB1B-PAK6 readthrough) This gene represents readthrough transcription between the genes BUB1B (mitotic checkpoint serine/threonine-protein kinase BUB1 beta) and PAK6 (serine/threonine-protein kinase PAK 6). The protein encoded by the readthrough transcripts is the same as the product of the downstream gene (PAK6). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
PAK6 (HGNC:16061): (p21 (RAC1) activated kinase 6) This gene encodes a member of a family of p21-stimulated serine/threonine protein kinases, which contain an amino-terminal Cdc42/Rac interactive binding (CRIB) domain and a carboxyl-terminal kinase domain. These kinases function in a number of cellular processes, including cytoskeleton rearrangement, apoptosis, and the mitogen-activated protein (MAP) kinase signaling pathway. The protein encoded by this gene interacts with androgen receptor (AR) and translocates to the nucleus, where it is involved in transcriptional regulation. Changes in expression of this gene have been linked to prostate cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 15-40218461-C-T is Benign according to our data. Variant chr15-40218461-C-T is described in ClinVar as Benign. ClinVar VariationId is 224924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.77 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0218 (3316/152282) while in subpopulation NFE AF = 0.0305 (2072/68024). AF 95% confidence interval is 0.0294. There are 57 homozygotes in GnomAd4. There are 1693 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 57 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001211.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BUB1B
NM_001211.6
MANE Select
c.2856C>Tp.Asp952Asp
synonymous
Exon 22 of 23NP_001202.5
BUB1B-PAK6
NM_001128628.3
c.-201+794C>T
intron
N/ANP_001122100.1
BUB1B-PAK6
NM_001128629.3
c.-118+794C>T
intron
N/ANP_001122101.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BUB1B
ENST00000287598.11
TSL:1 MANE Select
c.2856C>Tp.Asp952Asp
synonymous
Exon 22 of 23ENSP00000287598.7O60566-1
BUB1B
ENST00000412359.7
TSL:2
c.2898C>Tp.Asp966Asp
synonymous
Exon 22 of 23ENSP00000398470.3O60566-3
BUB1B
ENST00000918306.1
c.2958C>Tp.Asp986Asp
synonymous
Exon 23 of 24ENSP00000588365.1

Frequencies

GnomAD3 genomes
AF:
0.0218
AC:
3315
AN:
152164
Hom.:
57
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00509
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00897
Gnomad ASJ
AF:
0.0331
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00807
Gnomad FIN
AF:
0.0651
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0305
Gnomad OTH
AF:
0.0215
GnomAD2 exomes
AF:
0.0237
AC:
5928
AN:
250472
AF XY:
0.0240
show subpopulations
Gnomad AFR exome
AF:
0.00481
Gnomad AMR exome
AF:
0.0125
Gnomad ASJ exome
AF:
0.0308
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0613
Gnomad NFE exome
AF:
0.0290
Gnomad OTH exome
AF:
0.0264
GnomAD4 exome
AF:
0.0257
AC:
37498
AN:
1458640
Hom.:
596
Cov.:
30
AF XY:
0.0257
AC XY:
18632
AN XY:
725728
show subpopulations
African (AFR)
AF:
0.00413
AC:
138
AN:
33436
American (AMR)
AF:
0.0129
AC:
576
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.0300
AC:
782
AN:
26090
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39664
South Asian (SAS)
AF:
0.0121
AC:
1044
AN:
86042
European-Finnish (FIN)
AF:
0.0583
AC:
3113
AN:
53378
Middle Eastern (MID)
AF:
0.0205
AC:
118
AN:
5762
European-Non Finnish (NFE)
AF:
0.0273
AC:
30280
AN:
1109290
Other (OTH)
AF:
0.0240
AC:
1445
AN:
60290
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
1819
3638
5456
7275
9094
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1054
2108
3162
4216
5270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0218
AC:
3316
AN:
152282
Hom.:
57
Cov.:
32
AF XY:
0.0227
AC XY:
1693
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.00508
AC:
211
AN:
41562
American (AMR)
AF:
0.00896
AC:
137
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0331
AC:
115
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00849
AC:
41
AN:
4828
European-Finnish (FIN)
AF:
0.0651
AC:
689
AN:
10590
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0305
AC:
2072
AN:
68024
Other (OTH)
AF:
0.0213
AC:
45
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
172
345
517
690
862
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0280
Hom.:
55
Bravo
AF:
0.0173
Asia WGS
AF:
0.00404
AC:
14
AN:
3476
EpiCase
AF:
0.0338
EpiControl
AF:
0.0297

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
2
not provided (2)
-
-
1
Colorectal cancer (1)
-
-
1
Mosaic variegated aneuploidy syndrome 1 (1)
-
-
1
Premature chromatid separation trait (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Benign
5.3
DANN
Benign
0.76
PhyloP100
1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.18
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1802286; hg19: chr15-40510662; COSMIC: COSV55012097; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.